Skip to main content
Equibles
ESLA logo

ESLA · Estrella Immunopharma, Inc. · Webcasts, Transcripts & Audio

Track ESLA — free

Use ESLA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ESLA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.47 -0.01 (-1.47%) At close · Oct 2
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern. If the Company is unable to obtain adequate financing or generate significant revenue, it may be required to curtail or cease its operations.”
View the 10-Q filed Aug 13, 2026
Market Cap
$20.92M
Shares
43.50M
Volume · Oct 2 14.49K Avg daily vol (3M) 37.45K

Estrella Immunopharma, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Estrella Immunopharma, Inc. (ESLA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

No Webcasts Available

No webcast events are available for this stock yet.

Key facts CIK 1844417 CUSIP 297584104 13F (30d) 1 filings 1 filers Visit website Investor relations